Sight is vital to our health and well-being.
In fact, people fear vision loss more than losing hearing, memory, speech or even a limb. Vision research is helping every day — producing exciting new insights about eye disease, developing innovations to restore sight, and driving clinical breakthroughs that are helping all of us see the future more clearly.
IN THE NEWS
If We’re Serious About Healthcare Equity and Access, We Must Support Autonomous AI
The Hill, October 17, 2020
Image-Guided Technology can Improve Cataract Surgery Outcomes
Healio News, October 17, 2020
Combating Diabetes-Induced Blindness
Texas A&M Today, October 16, 2020
Can Vision Research Help the Development of a COVID-19 Vaccine?
There’s a not-so-new genetic technology – in fact, ophthalmologists already use it to reverse an incurable type of blindness – that may well prove the SARS-CoV-2 magic bullet the world so desperately seeks. It leverages a unique vaccine strategy, called adeno-associated viral (AAV) vector, to deliver a powerful knock-out punch to COVID-19 before it can establish a foothold in the human body.
Visionary Scientist
Lotfi Merabet, OD, PhD, MPH, is a clinician scientist and a member of the Vision Rehabilitation Service at Massachusetts Eye and Ear. His research focuses on diagnosis and rehabilitation approaches for children with cerebral visual impairment (CVI) and how the brain changes due to ocular or cerebral causes of blindness. His most influential work has been on developing virtual environments and video game-based learning strategies to improve navigation and other cognitive skills in blind adolescents.
AAO 2020: November 13-15
The American Academy of Ophthalmology’s annual meeting is fully online for 2020. Log in for lively discussions, clinical pearls, fun activities and live interaction with presenters and industry.
VISION RESEARCH IS AN INVESTMENT IN A BETTER FUTURE
As NIH Director Frances Collins put it, “Due to the architecture, accessibility, and the elegance of the eye, vision research has always been a few steps ahead in biomedical research.”